文档介绍：晚期胃癌的靶向治疗进展
晚期胃癌的靶向治疗进展晚期胃癌的靶向治疗进展靶向药物为晚期胃癌患者带来新的希望Murad , et al. Cancer 1993; 72:37–41. U, et al. J Clin Oncol 2000; 18:2648–2657. JA, et al. ASCO Gastrointestinal Cancers Symposium 2009; Abstract 8. Cutsem E, et al. J Clin Oncol 2006; 24:4991–4997. 5 .Dank M, et al. Ann Oncol 2008; 19:1450–1457. 6. Cunningham D, et al. Med 2008; 358:36–46. 7. Kang , et al. Ann Oncol 2009; 20:666–673. 8. Van Cutsem E, et al. J Clin Oncol 2009; 27:Abstract 4509. 9. Fuchs CS, et al. Lancet. 2014 Jan 4;383(9911):31-9. 10. ASCO # X/FC*(8)EOX (6)XP (7)ECX (6)ECF (6)DCF (4)EOF (6)IF (5)CF (4)FAMTX (2)BSC (1)C+S1 (3)HER2 IHC 2+ / FISH+ 和 IHC 3+雷莫卢单抗 (9)阿帕替尼 (10)一线 二线 二线后细胞毒药物治疗进入平台期靶向治疗更新
”通过阅读科技书籍，我们能丰富知识，培养逻辑思维能力；
靶向药物为晚期胃癌患者带来新的希望
Murad , et al. Cancer 1993; 72:37–41. U, et al. J Clin Oncol 2000; 18:2648–2657. JA, et al. ASCO Gastrointestinal Cancers Symposium 2009; Abstract 8. Cutsem E, et al. J Clin Oncol 2006; 24:4991–4997. 5 .Dank M, et al. Ann Oncol 2008; 19:1450–1457. 6. Cunningham D, et al. Med 2008; 358:36–46. 7. Kang , et al. Ann Oncol 2009; 20:666–673. 8. Van Cutsem E, et al. J Clin Oncol 2009; 27:Abstract 4509. 9. Fuchs CS, et al. Lancet. 2014 Jan 4;383(9911):31-9. 10. ASCO #4003.
曲妥珠单抗 X/FC*(8)
EOX (6)
XP (7)
ECX (6)
ECF (6)
DCF (4)
EOF (6)
IF (5)
CF (4)
FAMTX (2)
BSC (1)
C+S1 (3)
HER2 IHC 2+ / FISH+ 和 IHC 3+
雷莫卢单抗 (9)
阿帕替尼 (10)
一线 二线 二线后